Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation

[1]  Stuart R Dalziel,et al.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. , 2017, The Cochrane database of systematic reviews.

[2]  F. Walther,et al.  Aerosol delivery of synthetic lung surfactant , 2014, PeerJ.

[3]  Reint K Jellema,et al.  Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution, and lung compliance in spontaneously breathing preterm lambs , 2014, Pediatric Research.

[4]  M. Wolfson,et al.  Aerosolized KL4 surfactant improves short‐term survival and gas exchange in spontaneously breathing newborn pigs with hydrochloric acid‐induced acute lung injury , 2014, Pediatric pulmonology.

[5]  W. Schoel,et al.  Nebulizing poractant alfa versus conventional instillation: Ultrastructural appearance and preservation of surface activity , 2014, Pediatric pulmonology.

[6]  E. Ruiz-Del-Yerro,et al.  Acute and sustained effects of aerosolized vs. bolus surfactant therapy in premature lambs with respiratory distress syndrome , 2013, Pediatric Research.

[7]  D. Osborn,et al.  Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. , 2012, The Cochrane database of systematic reviews.

[8]  Reint K Jellema,et al.  New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs , 2012, PloS one.

[9]  L. Mecklenburg,et al.  The non-intubated, spontaneously breathing, continuous positive airway pressure (CPAP) ventilated pre-term lamb: a unique animal model. , 2012, Reproductive toxicology.

[10]  J. Pillow.  Tidal volume, recruitment and compliance in HFOV: same principles, different frequency , 2012, European Respiratory Journal.

[11]  J. Pillow,et al.  Innovation in Surfactant Therapy II: Surfactant Administration by Aerosolization , 2012, Neonatology.

[12]  G. Sant’Anna,et al.  Severe airway obstruction during surfactant administration using a standardized protocol: a prospective, observational study , 2012, Journal of Perinatology.

[13]  N. Uraş,et al.  A Randomized, Controlled Trial of Poractant Alfa versus Beractant in the Treatment of Preterm Infants with Respiratory Distress Syndrome , 2011, American Journal of Perinatology.

[14]  W. Göpel,et al.  Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial , 2011, The Lancet.

[15]  M. Wolfson,et al.  Dose-Response to Aerosolized KL4 Surfactant in the Spontaneously Breathing CPAP-Supported Preterm Lamb , 2011, Pediatric Research.

[16]  A. V. van Kaam,et al.  Surfactant Replacement Therapy in Preterm Infants: A European Survey , 2011, Neonatology.

[17]  N. Finer,et al.  An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[18]  A. Arzhavitina,et al.  Surface active drugs significantly alter the drug output rate from medical nebulizers. , 2010, International journal of pharmaceutics.

[19]  N. Kloosterboer,et al.  Pulmonary Vascular Endothelial Growth Factor Expression and Disaturated Phospholipid Content in a Chicken Model of Hypoxia-Induced Fetal Growth Restriction , 2009, Neonatology.

[20]  J. Pillow,et al.  Oxygen, temperature and humidity of inspired gases and their influences on airway and lung tissue in near-term lambs , 2009, Intensive Care Medicine.

[21]  J. Wirbelauer,et al.  The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome , 2009, Journal of Perinatology.

[22]  R. Soll,et al.  Animal derived surfactant extract for treatment of respiratory distress syndrome. , 2009, The Cochrane database of systematic reviews.

[23]  A. Jobe,et al.  Betamethasone for lung maturation: testing dose and formulation in fetal sheep. , 2007, American journal of obstetrics and gynecology.

[24]  F. Pillekamp,et al.  Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤27 weeks) , 2007, Paediatric anaesthesia.

[25]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[26]  A. Jobe,et al.  Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. , 2005, American journal of respiratory and critical care medicine.

[27]  P. Sly,et al.  Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol. , 2000, American journal of respiratory and critical care medicine.

[28]  H. Amthauer,et al.  Endotracheal surfactant atomization: An alternative to bolus instillation? , 2000, Critical care medicine.

[29]  B. Winbladh,et al.  Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome , 2000, Acta paediatrica.

[30]  S. Oetomo,et al.  Surfactant nebulisation: lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits , 1997, Intensive Care Medicine.

[31]  T. Schaible,et al.  To the editor: Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants , 1997, Pediatric pulmonology.

[32]  R. Soll,et al.  Clinical trials of natural surfactant extract in respiratory distress syndrome. , 1993, Clinics in perinatology.

[33]  A. Jobe,et al.  Aerosolized surfactant treatment of preterm lambs. , 1991, Journal of applied physiology.

[34]  K. Pringle.  Human Fetal Lung Development and Related Animal Models , 1986, Clinical obstetrics and gynecology.

[35]  K. Pringle.  Human fetal lung development and related animal models. , 1986 .

[36]  T. Austin,et al.  Physiologic changes associated with endotracheal intubation in preterm infants , 1984, Critical care medicine.

[37]  J C Stewart,et al.  Colorimetric determination of phospholipids with ammonium ferrothiocyanate. , 1980, Analytical biochemistry.

[38]  R. Mason,et al.  Isolation of disaturated phosphatidylcholine with osmium tetroxide. , 1976, Journal of lipid research.

[39]  M. Davis,et al.  Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. , 1976, Environmental research.

[40]  Y. Alarie,et al.  MICROAEROSOL ADMINISTRATION OF SYNTHETIC BETA-GAMMA-DIPALMITOYL-L-ALPHA-LECITHIN IN THE RESPIRATORY DISTRESS SYNDOME: A PRELIMINARY REPORT. , 1964, Canadian Medical Association journal.

[41]  B. Kramer,et al.  Amplification of steroid-mediated SP-B expression by physiological levels of caffeine. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[42]  S. Donn.  Preliminary evaluation of a new technique of minimally invasive surfactant therapy , 2012 .

[43]  F. Moya.  Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study , 2012 .